VOYA Investment Management
KURA icon

VOYA Investment Management’s Kura Oncology KURA Stock Holding History

VOYA Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Sell
14,360
-296
-2% -$2.54K ﹤0.01% 2184
2025
Q4 		$152K Hold
14,656
– – ﹤0.01% 2197
2025
Q3 		$130K Sell
14,656
-6,900
-32% -$49.2K ﹤0.01% 2262
2025
Q2 		$124K Buy
21,556
+1,648
+8% +$10.1K ﹤0.01% 2439
2025
Q1 		$131K Sell
19,908
-2,108
-10% -$16.4K ﹤0.01% 2366
2024
Q4 		$192K Sell
22,016
-54,849
-71% -$789K ﹤0.01% 2407
2024
Q3 		$1.5M Sell
76,865
-610
-0.8% -$12.4K ﹤0.01% 1441
2024
Q2 		$1.6M Buy
77,475
+54,051
+231% +$1.11M ﹤0.01% 1392
2024
Q1 		$500K Sell
23,424
-5,735
-20% -$111K ﹤0.01% 2016
2023
Q4 		$419K Buy
29,159
+423
+1% +$4.16K ﹤0.01% 2166
2023
Q3 		$262K Buy
28,736
+2,904
+11% +$29.5K ﹤0.01% 2379
2023
Q2 		$273K Buy
25,832
+1,149
+5% +$13.6K ﹤0.01% 2423
2023
Q1 		$302K Hold
24,683
– – ﹤0.01% 2327
2022
Q4 		$306K Hold
24,683
– – ﹤0.01% 2322
2022
Q3 		$337K Hold
24,683
– – ﹤0.01% 2277
2022
Q2 		$452K Hold
24,683
– – ﹤0.01% 1902
2022
Q1 		$397K Hold
24,683
– – ﹤0.01% 2032
2021
Q4 		$346K Sell
24,683
-578
-2% -$9.36K ﹤0.01% 2220
2021
Q3 		$473K Sell
25,261
-568
-2% -$10.7K ﹤0.01% 2082
2021
Q2 		$539K Sell
25,829
-1,925
-7% -$47.8K ﹤0.01% 2039
2021
Q1 		$785K Buy
27,754
+1,272
+5% +$40.2K ﹤0.01% 1745
2020
Q4 		$865K Buy
26,482
+7,882
+42% +$277K ﹤0.01% 1590
2020
Q3 		$570K Hold
18,600
– – ﹤0.01% 1594
2020
Q2 		$303K Buy
18,600
+2,369
+15% +$34.2K ﹤0.01% 1955
2020
Q1 		$161K Hold
16,231
– – ﹤0.01% 2209
2019
Q4 		$223K Buy
16,231
+4,063
+33% +$60.2K ﹤0.01% 2331
2019
Q3 		$185K Hold
12,168
– – ﹤0.01% 2263
2019
Q2 		$240K Hold
12,168
– – ﹤0.01% 2201
2019
Q1 		$202K Hold
12,168
– – ﹤0.01% 2263
2018
Q4 		$171K Buy
12,168
+1,878
+18% +$24.9K ﹤0.01% 2267
2018
Q3 		$180K Hold
10,290
– – ﹤0.01% 2370
2018
Q2 		$187K Buy
+10,290
New +$174K ﹤0.01% 2384

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's KURA Position: Q1 2026 in Review

VOYA Investment Management reduced its Kura Oncology (KURA) stake by 2% in Q1 2026, selling an estimated $2.54K and leaving 14,360 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

VOYA Investment Management first reported a position in KURA in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.6M in Q2 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • VOYA Investment Management held 14,360 shares of Kura Oncology worth $117K as of Q1 2026.
  • VOYA Investment Management sold 296 Kura Oncology shares in Q1 2026, an estimated $2.54K.
  • Kura Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2184 holding.
  • VOYA Investment Management first reported a position in Kura Oncology in Q2 2018 and has held it in 32 quarters since.
  • VOYA Investment Management's Kura Oncology position peaked at $1.6M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.